KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.
Therapeutic Advances In Medical Oncology
Cinausero, Marika M; Laprovitera, Noemi N; De Maglio, Giovanna G; Gerratana, Lorenzo L; Riefolo, Mattia M; Macerelli, Marianna M; Fiorentino, Michelangelo M; Porcellini, Elisa E; Buoro, Vanessa V; Gelsomino, Francesco F; Squadrilli, Anna A; Fasola, Gianpiero G; Negrini, Massimo M; Tiseo, Marcello M; Ferracin, Manuela M; Ardizzoni, Andrea A
Publication Date: 2019
Variant appearance in text: ERBB2: V777_G778insGSP